214 related articles for article (PubMed ID: 32942976)
1. An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents.
Mao Y; Soni K; Sangani C; Yao Y
Curr Top Med Chem; 2020; 20(28):2599-2633. PubMed ID: 32942976
[TBL] [Abstract][Full Text] [Related]
2. An overview of quinoline as a privileged scaffold in cancer drug discovery.
Musiol R
Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
[TBL] [Abstract][Full Text] [Related]
3. Recent contributions of quinolines to antimalarial and anticancer drug discovery research.
Van de Walle T; Cools L; Mangelinckx S; D'hooghe M
Eur J Med Chem; 2021 Dec; 226():113865. PubMed ID: 34655985
[TBL] [Abstract][Full Text] [Related]
4. Quinoline as a privileged scaffold in cancer drug discovery.
Solomon VR; Lee H
Curr Med Chem; 2011; 18(10):1488-508. PubMed ID: 21428893
[TBL] [Abstract][Full Text] [Related]
5. Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.
Sharma S; Singh A; Sharma S; Sharma R; Singh J; Kinarivala N; Nepali K; Liou JP
Anticancer Agents Med Chem; 2021; 21(3):288-315. PubMed ID: 32900354
[TBL] [Abstract][Full Text] [Related]
6. A review on anticancer potential of bioactive heterocycle quinoline.
Afzal O; Kumar S; Haider MR; Ali MR; Kumar R; Jaggi M; Bawa S
Eur J Med Chem; 2015 Jun; 97():871-910. PubMed ID: 25073919
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents.
Sharma V; Mehta DK; Das R
Mini Rev Med Chem; 2017; 17(16):1557-1572. PubMed ID: 28494729
[TBL] [Abstract][Full Text] [Related]
8. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry.
Yadav P; Shah K
Bioorg Chem; 2021 Apr; 109():104639. PubMed ID: 33618829
[TBL] [Abstract][Full Text] [Related]
9. A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines.
Gopaul K; Shintre SA; Koorbanally NA
Anticancer Agents Med Chem; 2015; 15(5):631-46. PubMed ID: 25511516
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
11. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
12. Quinoline: An Attractive Scaffold in Drug Design.
Moor LFE; Vasconcelos TRA; da R Reis R; Pinto LSS; da Costa TM
Mini Rev Med Chem; 2021; 21(16):2209-2226. PubMed ID: 33568032
[TBL] [Abstract][Full Text] [Related]
13. Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent.
Mittal RK; Purohit P
Anticancer Agents Med Chem; 2020; 20(16):1981-1991. PubMed ID: 32560612
[TBL] [Abstract][Full Text] [Related]
14. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.
Vyas VK; Qureshi G; Oza D; Patel H; Parmar K; Patel P; Ghate MD
Bioorg Med Chem Lett; 2019 Apr; 29(7):917-922. PubMed ID: 30738663
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents.
Man RJ; Jeelani N; Zhou C; Yang YS
Anticancer Agents Med Chem; 2021; 21(7):825-838. PubMed ID: 32416703
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review on the biological interest of quinoline and its derivatives.
Matada BS; Pattanashettar R; Yernale NG
Bioorg Med Chem; 2021 Feb; 32():115973. PubMed ID: 33444846
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
19. The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents.
Yadav P; Kumar A; Althagafi I; Nemaysh V; Rai R; Pratap R
Curr Top Med Chem; 2021 Oct; 21(17):1587-1622. PubMed ID: 34042035
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
